サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542775

冠動脈バイパスグラフト（CABG）の世界市場

Coronary Artery Bypass Grafts (CABG)

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
冠動脈バイパスグラフト（CABG）の世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

冠動脈バイパスグラフト（CABG）の世界市場は2030年までに2億3,300万米ドルに達する見込み

2023年に1億7,020万米ドルと推定される冠動脈バイパスグラフト（CABG）の世界市場は、2023～2030年の分析期間においてCAGR 4.6%で成長し、2030年には2億3,300万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるオフポンプCABGは、CAGR 4.1%を記録し、分析期間終了時には1億910万米ドルに達すると予測されます。オンポンプCABGセグメントの成長率は、分析期間中CAGR 3.3%と推定されます。

米国市場は4,600万米ドルと推定、中国はCAGR4.2%で成長予測

米国の冠動脈バイパスグラフト（CABG）市場は、2023年に4,600万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3,660万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.4％と3.6％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の冠動脈バイパスグラフト（CABG）市場- 主要動向と促進要因のまとめ

心が反抗するとき：現代生活が冠動脈性心疾患の火種となるメカニズム

冠動脈性心疾患（CHD）は、現代文明における最も手ごわい健康課題の1つであり、座りがちな生活、食生活の乱れ、強いストレスなどを特徴とする現代のライフスタイルと密接に結びついています。世界の死因の第一位であるCHDは、心臓血管の健康にとって有害な環境を促進する工業化と都市化の致命的な結果を象徴しています。加工食品の消費量の増加、身体活動の低下、公害への暴露などの要因が、この疾患の発生率を大幅に上昇させ、重大な公衆衛生の危機となっています。この疾患は、個人と家族に大きな精神的・経済的負担を強いるだけでなく、世界中のヘルスケアシステムに莫大な圧力をかけています。社会が発展し続ける中、現代文明への影響を軽減するためには、公衆衛生への取り組み、ライフスタイルの改善、質の高いヘルスケアへのアクセスを通じて、CHDの根本原因に対処することが不可欠です。

冠動脈バイパス術はどのように心臓治療に革命をもたらしているのか？

冠動脈バイパス移植術（CABG）は、重度の冠動脈性心疾患（CHD）患者の心臓への血流を改善するために用いられる重要な外科手術です。CHDは、冠動脈がプラークの蓄積により硬化して狭くなり、心臓への血流が減少して心臓発作につながる可能性がある場合に起こります。CABGでは、体の別の部位から血管を採取し、閉塞部位の上下にある冠動脈に移植することで、閉塞部位をバイパスします。これにより、血液は閉塞部を迂回して流れ、心筋に到達します。CABGは、特に複数の冠動脈が閉塞している患者や、他の治療法では効果が不十分な患者にとって効果的な救命処置であることが証明されており、より質の高い生活と心臓病の症状の軽減を提供しています。

どのような進歩がCABG手技を形成しているのか？

最近のCABG手技の進歩は成功率と患者の転帰を著しく向上させています。主要な技術革新のひとつは、心臓が動いている間に手術を行うことができるオフポンプ冠動脈バイパス術（OPCAB）の開発であり、これにより人工心肺装置が不要になった。この手技により、認知機能の低下や脳卒中など、心肺バイパスに伴う合併症が軽減されます。低侵襲直接冠動脈バイパス術（MIDCAB）は、胸壁を切開するのではなく、より小さな切開創を使用するもう一つの進歩であり、多くの場合、ロボットによる補助を伴い、より高い精度とより早い回復時間を提供します。このような技術の進歩により、CABGはより身近なものとなり、患者にとって困難なものではなくなり、術後の回復時間も大幅に短縮され、手技の全体的な有効性も向上しています。

CABGで患者や外科医が直面する課題とは？

CABG手技の進歩にもかかわらず、患者にも外科医にも影響する重大な課題がまだあります。主な課題の一つは合併症のリスクで、感染症、腎不全、心筋梗塞などが手術中あるいは手術後に起こりうる。また、移植片の長期的な成功も懸念されます。移植片は時間の経過とともに狭くなり、再手術を余儀なくされる可能性があるからです。外科医の立場からすると、手技の複雑さゆえに高い技術と経験が要求され、特にOPCABやMIDCABのような新しい手技は、すべての病院で利用できるとは限らないです。さらに、個々の患者にとって最も適切な手術方法に関する意思決定プロセスでは、患者の健康状態、動脈閉塞の重症度、他の病状の有無など、さまざまな要因を慎重に検討する必要があります。

何が冠動脈バイパスグラフト市場の成長を促進するのか？

冠動脈バイパス移植市場の成長は、世界人口の高齢化や、肥満、喫煙、運動不足などのライフスタイル要因による心血管系疾患の有病率の増加など、いくつかの要因によってもたらされます。また、医療用画像診断技術の進歩も、CHDの診断やCABGのような外科的介入の計画を改善したことから、重要な役割を果たしています。さらに、より優れた適合性と耐久性を提供する移植片用の、より新しく先進的な生体材料の開発が、移植片の採用拡大を後押ししています。新興市場の経済成長により、ヘルスケアのインフラが整備され、高度な手術手技が利用できるようになったため、世界中でCABG手術の実施件数が増加しています。さらに、CABGの有効性と安全性を高めることを目的とした臨床研究と臨床試験が進行中であることも、この市場の堅調な成長に寄与しています。これらの要因が相まって、CABGは依然として冠動脈性心疾患の基本的な治療選択肢であり、現代の心臓治療における重要な役割を反映しています。

調査対象企業の例（全41件）

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11336

Global Coronary Artery Bypass Grafts (CABG) Market to Reach US$233.0 Million by 2030

The global market for Coronary Artery Bypass Grafts (CABG) estimated at US$170.2 Million in the year 2023, is expected to reach US$233.0 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million by the end of the analysis period. Growth in the On-Pump CABG segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$46.0 Million While China is Forecast to Grow at 4.2% CAGR

The Coronary Artery Bypass Grafts (CABG) market in the U.S. is estimated at US$46.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Coronary Artery Bypass Grafts (CABG) Market - Key Trends and Drivers Summarized

When Hearts Rebel: How Modern Life Fuels the Fire of Coronary Heart Disease

Coronary heart disease (CHD) stands as one of the most formidable health challenges of modern civilization, closely linked to contemporary lifestyles characterized by sedentary behavior, poor dietary habits, and high stress. As the leading cause of death globally, CHD epitomizes the lethal consequences of industrialization and urbanization which promote environments detrimental to cardiovascular health. Factors such as increased consumption of processed foods, reduced physical activity, and exposure to pollution have substantially elevated the incidence of this disease, marking it as a critical public health crisis. This condition not only places a significant emotional and financial burden on individuals and families but also exerts immense pressure on healthcare systems worldwide. As societies continue to evolve, addressing the root causes of CHD through public health initiatives, improved lifestyle choices, and access to quality healthcare becomes imperative to alleviate its impact on modern civilization.

How Is Coronary Artery Bypass Grafting Revolutionizing Cardiac Care?

Coronary Artery Bypass Grafting (CABG) is a critical surgical procedure used to improve blood flow to the heart in patients with severe coronary heart disease (CHD). CHD occurs when the coronary arteries become hardened and narrowed due to the buildup of plaque, reducing blood flow to the heart and potentially leading to a heart attack. CABG involves taking a blood vessel from another part of the body and grafting it to the coronary artery above and below the blocked area, thus bypassing the blockage. This allows blood to flow around the obstruction and reach the heart muscle. CABG has proven to be an effective life-saving procedure, particularly for patients with multiple blocked coronary arteries and those who have not responded well to other treatments, offering them a higher quality of life and reduced symptoms of heart disease.

What Advancements Are Shaping CABG Techniques?

Recent advancements in CABG techniques have significantly enhanced the success rates and patient outcomes. One of the major innovations is the development of off-pump coronary artery bypass (OPCAB), which allows surgeons to perform the procedure while the heart is still beating, eliminating the need for a heart-lung machine. This technique reduces complications associated with cardiopulmonary bypass, such as cognitive decline and stroke. Minimally invasive direct coronary artery bypass (MIDCAB) is another advancement that uses smaller incisions rather than opening the chest wall and often involves robotic assistance, which provides greater precision and faster recovery times. These technological advancements have made CABG more accessible and less daunting for patients, significantly reducing postoperative recovery time and improving the overall efficacy of the procedure.

What Challenges Do Patients and Surgeons Face with CABG?

Despite the advancements in CABG techniques, there are still significant challenges that affect both patients and surgeons. One of the main challenges is the risk of complications, which can include infections, kidney failure, and heart attacks during or after surgery. The long-term success of the grafts is also a concern, as they can become narrowed over time, potentially leading to a repeat surgery. From a surgeon's perspective, the technical complexity of the procedure requires high skill and experience, particularly with newer techniques like OPCAB and MIDCAB, which may not be available in all hospitals. Additionally, the decision-making process regarding the most appropriate surgical approach for each individual patient involves careful consideration of various factors, including the patient’s health status, the severity of artery blockage, and the presence of other medical conditions.

What Drives the Growth in the Coronary Artery Bypass Graft Market?

The growth in the coronary artery bypass graft market is driven by several factors, including an aging global population and an increase in the prevalence of cardiovascular diseases, driven by lifestyle factors such as obesity, smoking, and physical inactivity. Advances in medical imaging technologies have also played a significant role, as they have improved the diagnosis of CHD and the planning of surgical interventions like CABG. Furthermore, the development of newer, more advanced biomaterials for grafts that offer better compatibility and durability is encouraging their increased adoption. Economic growth in emerging markets has led to improved healthcare infrastructure and access to advanced surgical techniques, thereby increasing the number of CABG procedures performed worldwide. Additionally, ongoing clinical research and trials aimed at enhancing the efficacy and safety of CABG contribute to the robust growth of this market. Together, these factors ensure that CABG remains a cornerstone treatment option for coronary heart disease, reflecting its vital role in contemporary cardiac care.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Coronary Artery Bypass Grafts (CABG) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Coronary Artery Disease Propels Demand for CABG
    • Advancements in Minimally Invasive Surgery Techniques Expand Market Reach
    • Aging Population Globally Drives Need for Effective CABG Procedures
    • Rising Healthcare Expenditure and Insurance Coverage Bolster CABG Accessibility
    • Emerging Markets Witness Increased Adoption of Advanced Cardiac Care
    • Cardiac Rehabilitation Developments Post-CABG Surgery Support Patient Recovery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Coronary Artery Bypass Grafts (CABG) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Off-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for On-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Minimally Invasive Direct by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Saphenous Vein Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Internal Thoracic Artery Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION